Trial Profile
A randomized comparison of once weekly epoetin alfa to extended schedule epoetin or darbepoetin in chemotherapy-associated anemia.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Feb 2016
Price :
$35
*
At a glance
- Drugs Darbepoetin alfa (Primary) ; Epoetin alfa (Primary)
- Indications Chemotherapy-induced anaemia
- Focus Therapeutic Use
- 02 Feb 2016 New trial record